Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
SEC Filings
All SEC Filings
Investors
Overview
News
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
All SEC Filings
Filter Filings:
View All
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12G
8-K
8-K/A
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFR14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
02/07/14
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
5
01/31/14
8-K
Current report filing
Related Documents
EX-4.1
EX-4.2
EX-4.3
EX-10.1
EX-10.2
EX-99.1
180
01/23/14
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Related Documents
EX-5.1
EX-23.2
10
12/27/13
10-K
Annual report pursuant to section 13 and 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
74
10/04/13
8-K
Current report filing
Related Documents
EX-10.1
EX-10.3
57
09/11/13
4
Statement of changes in beneficial ownership of securities
2
09/11/13
4
Statement of changes in beneficial ownership of securities
2
08/14/13
10-Q
Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-10.11
EX-10.13
EX-10.14
EX-10.15
EX-31.1
EX-31.2
EX-32.1
67
07/12/13
3
Statement of changes in beneficial ownership of securities
2
07/08/13
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
10
<< Previous
1...
44
45
46
47
48
49
50
51
52
53
Next >>